Merck Presses for Revision of Ljubljana Court Ruling in Krka Lawsuit
Novo Mesto, 18 November - The U.S. pharmaceutical Merck has filed a demand for a revision of a Ljubljana Higher Court procedure after the court ruled in favour of Slovenian drug maker Krka in Merck's suit of patent violation, the Novo mesto-company said on Monday.
The rest of this news item is available to subscribers.
The news item consists of 1.031 characters (without spaces) or 202 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.